Germany’s medical marijuana program is booming despite the massive legal obstacles that suppliers and doctors face on a daily basis

The German medical cannabis industry is laudable but full of legal debacles. The process of obtaining federal government approval to sell, manufacture, or import medical cannabis into the country is rigorous.

Foreigners are mostly impressed with the twists and turns required at each stage of obtaining a cannabis business license. Some of these unique practices have been said to defy logic.

Medical cannabis industry in Germany

The German medical cannabis market has exceeded expectations since it was founded in 2017. It has grown to become the largest medical cannabis market in Europe.

The strategies of the German federal government and other stakeholders have created one of the most attractive markets for investors and other large medical cannabis companies. Because of its favorable policies and strong demand, international cannabis companies have flocked to the German cannabis market.

Currently, Germany is solely responsible for enforcing cannabis growing plans through areas with optimal temperatures and lower labor costs. Germany was able to manufacture, source, and export medicinal cannabis products domestically to consumers in European countries and other distant countries. The country’s medical cannabis industry is indeed one of the best and largest in the world today.

Things to know

Germany has a pharmaceutical infrastructure to meet the sales needs of medical cannabis companies. Contrary to most people’s initial assumption that these infrastructures have a clear and simple path, the pharmaceutical system in place is complex.

The reason for this complexity is that federal law defines cannabis as a controlled narcotic.

All dealers in the German cannabis market must always find a way around this federal classification of the drug as a narcotic.

In October 2020, the European Union decided to include low-THC hemp, but this decision sparked a lot of backlash. A series of lawsuits and embarrassing events, both medical and non-medical, of commercial cannabis sales followed.

When the federal government approved the use of medical cannabis, cannabis as medicine became part of the system. The system only allowed the import and registration of cannabis strains and brands. All of this alone does not generate the high sales that are seen on a daily basis.

In the United States of America, advertising cannabis drugs to potential customers or patients is prohibited. This means that no turnover can be generated via this medium.

What Germany and the US are doing to generate sales of medical cannabis is divided into a three-step process. This is an expensive process that ensures that patients are prescribed cannabis medication. The process is commonly referred to as “physician training”.

The steps to start prescribing medical cannabis for patients are

Identify a supplier

This is the first step, which is quite difficult for new distributors who have no experience in the industry. Getting into the cannabis specialty business is not easy. Before anyone can get their permanent permit and other required permits, they must first be connected with a qualified supplier. It’s hard to find companies that want to partner with aspiring distributors. The presence of only one domestically grown cannabis dealer in the country also makes this situation worse.

A few years ago, potential distributors identified Canadian companies with plans to expand internationally, particularly into Europe. Others can also opt for Bedrocan, which is just across the DACH border. Currently Bedrocan has limited the number of new distributors it would like to work with.

Cannabis prescription in the Gulf of Germany

The real battle for a sales partner begins after the supplier has been selected and all the necessary documents have been prepared.

In order for a retailer’s products to be sold in German pharmacies and pharmacies, he must be ready to inform doctors about his product.

After completing the “Doctor Education” task, patients can be found who are committed to their product, whenever doctors prescribe cannabis with it.

Privately insured people do not have to go through difficult and dichotomous situations before receiving their German medical cannabis prescription. In larger cities, the process becomes easier. When you have private insurance, you are ready to pay out of pocket for the counseling visit and the cannabis given to you.

Pain clinics are popular centers run by doctors who care about the wellbeing of their patients. The patients who visit this facility already have a probable and pre-diagnosed condition. The doctors at the pain center can continue with the treatment methods instead of starting over.

The longest route to prescribing cannabis is for a resident with statutory health insurance. The first challenge is to find willing doctors. After that, the patient must work hand-in-hand with the doctor to sort out forms and obtain approval from the region. Patients are sometimes allowed to ask for their preferred brand of cannabis after they have been prescribed it, they can send the prescription to a specialist pharmacy.

Distributors go through various methods in order to reach the prescribing physicians and their patients. Some of these methods include the free press, sponsoring pharmaceutical or health events, and hiring representatives in the pharmaceutical industry.

Another complication that affects traders is the inconsistent availability of doctors and their willingness to prescribe cannabis drugs across states in the country.

In Hesse, doctors who work with statutory health insurance patients usually only have to deal with two cannabis patients at the same time. While the Frankfurt city authorities refused to reveal the names of newly trained cannabis doctors.

Final note

Sales partners in Germany have an online program for addressing patients. Social media platforms such as Facebook, Twitter, Instagram, Zoom, etc. are used to disseminate information about a regular drug supply. They are also used to run guided ads on newly procured medicines.

The greatest challenge that remains to be overcome is to fully ensure the year-round prescription of cannabis drugs for insured and uninsured patients.

For the momentum to change, there are still some legal issues that need to be resolved. The legal reforms also need to be improved in order to implement better marketing strategies.

GERMANY WILL BE GREEN, READ MORE ..

GERMANY HAS A MEDICAL MARIJUANA PROBLEM, CAN YOU FIX IT?

OR..

OVER 20,000 GERMAN PHARMACIES SELLING CANADIAN CANNABIS!